Exploring treatment options for retinitis pigmentosa? Get a free evaluation.
Nome helps families navigating RP understand whether a personalized genetic therapy path may be possible for their specific variant — then maps the steps to move forward. No waiting. No cost for the first step.
How it works
Share your diagnosis
Submit your genetic test report or diagnosis details. We review it at no cost and evaluate whether a personalized therapy approach could work for your RP variant. No commitment, no money down.
AI Analysis
Nome's platform, Togo, evaluates your specific mutation against every known therapeutic option — ASOs, gene therapy, and drug repurposing. If a personalized path isn't viable for your variant, we tell you clearly and explain why.
Expert Review + Summary Report
A PhD scientist validates every AI-generated finding. You receive a free Summary Report with a plain-English overview of your options.
Who this is for
- check_circleDiagnosed with retinitis pigmentosa or an inherited retinal disease
- check_circleConfirmed genetic diagnosis with a disease-causing variant
- check_circleYour variant may be targetable with a personalized antisense therapy (ASO)
* Don't have genetic test results yet? Start the evaluation anyway — we'll help you figure out next steps.
Built by someone who's been where you are
Nome's founder was diagnosed with a rare retinal disease at seventeen and told there was nothing to do — learn braille, train with a white cane, accept vision loss. After a decade of chasing answers, he discovered the science for personalized genetic therapies already existed, but the system to access it did not. He built Nome to fix that.
Every evaluation is built by AI and validated by PhDs — combining speed with the rigor families deserve.
Frequently Asked Questions
Answers to the questions families ask most when exploring RP treatment options.
Who is Nome for?add
Nome is built for people navigating inherited rare genetic diseases, plus the clinicians and organizations helping them. This page is not intended for cancer-related care.
Why collect diagnosis information up front?add
The genetics and disease context determine whether a personalized therapy path is realistic, so upfront detail is what makes the evaluation useful instead of generic.
What does the evaluation cost?add
The initial evaluation is completely free. Nome reviews your diagnosis and genetic information at no cost to determine whether a personalized therapy path may be viable for your variant.
Is this medical advice or a diagnosis?add
No. Nome is not a healthcare provider. The service is designed to help families and care teams evaluate options and coordinate next steps alongside qualified medical professionals.
What happens after the evaluation?add
If a personalized therapy path looks viable for your variant, Nome provides a clear roadmap of next steps and can help coordinate the work needed to move forward. If it's not viable, we tell you clearly and explain why. Either way, you get a real answer.
Ready to find out what's possible for your RP variant?
Start your free evaluation and get a clear answer — built by AI, validated by experts — on whether a personalized therapy path may exist for you.